133 related articles for article (PubMed ID: 38311898)
1. A Case of Myxoid Pleomorphic Liposarcoma with Rhabdoid Cells: A Diagnostic Pitfall.
Arai T; Kato I; Kawabata Y; Tsujimoto S; Ishikawa Y; Kato S; Takeyama M; Yamanaka S; Kohashi K; Oda Y; Fujii S
Int J Surg Pathol; 2024 Feb; ():10668969241226695. PubMed ID: 38311898
[TBL] [Abstract][Full Text] [Related]
2. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification.
Murshed KA; Abo Samra H; Ammar A
Head Neck Pathol; 2022 Mar; 16(1):288-293. PubMed ID: 34089125
[TBL] [Abstract][Full Text] [Related]
3. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
[TBL] [Abstract][Full Text] [Related]
4. DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma.
Scapa JV; Cloutier JM; Raghavan SS; Peters-Schulze G; Varma S; Charville GW
Am J Surg Pathol; 2021 Feb; 45(2):230-239. PubMed ID: 32815829
[TBL] [Abstract][Full Text] [Related]
5. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
6. Myxoid liposarcoma with pleomorphic cells: Report of two cases with molecular confirmation of FUS gene rearrangements.
Uchihashi K; Matsuyama A; Nakayama M; Sakamoto A; Shiba E; Hisaoka M
Pathol Res Pract; 2016 Nov; 212(11):1067-1070. PubMed ID: 27515548
[TBL] [Abstract][Full Text] [Related]
7. Myxoid pleomorphic liposarcoma.
Fadaei S; Cordier F; Ferdinande L; Van Dorpe J; Creytens D
Histol Histopathol; 2024 Feb; ():18724. PubMed ID: 38450446
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Pleomorphic Myxoid Liposarcoma in a Patient With Li-Fraumeni Syndrome.
Zare SY; Leivo M; Fadare O
Int J Surg Pathol; 2020 Apr; 28(2):225-228. PubMed ID: 31559875
[TBL] [Abstract][Full Text] [Related]
9. Liposarcoma of the pleural cavity.
Kawai T; Nakashima H; Washimi K; Yokose T; Matsuo T; Nakayama M; Shinohara N; Kuroda H; Ishida K; Akiba J; Ishikawa M; Urabe S; Shiraishi J; Shiraishi T; Sakamoto A; Matsukuma S
Hum Pathol; 2023 Jun; 136():105-113. PubMed ID: 37023867
[TBL] [Abstract][Full Text] [Related]
10. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
[No Abstract] [Full Text] [Related]
11. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
13. Myxoma versus myxoid liposarcoma involving the kidneys.
Findeis SK; Salicru MN; Agarwal A
Proc (Bayl Univ Med Cent); 2019 Jul; 32(3):402-404. PubMed ID: 31384201
[TBL] [Abstract][Full Text] [Related]
14. Atypical Pleomorphic Lipomatous Tumor: Expanding Our Current Understanding in a Clinicopathologic Analysis of 64 Cases.
Anderson WJ; Fletcher CDM; Jo VY
Am J Surg Pathol; 2021 Sep; 45(9):1282-1292. PubMed ID: 33782225
[TBL] [Abstract][Full Text] [Related]
15. Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant.
Agaimy A; Michal M; Hadravsky L; Michal M
Hum Pathol; 2018 Jul; 77():20-27. PubMed ID: 29307627
[TBL] [Abstract][Full Text] [Related]
16. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study.
Kojima N; Kubo T; Mori T; Satomi K; Matsushita Y; Iwata S; Yatabe Y; Ichimura K; Kawai A; Ichikawa H; Yoshida A
Virchows Arch; 2024 Jan; 484(1):71-81. PubMed ID: 37704823
[TBL] [Abstract][Full Text] [Related]
17. [Myxiod pleomorphic liposarcoma: a clinicopathological and molecular genetic analysis of six cases].
Zheng XC; Huang HJ; You J; Lin XY; Chen DR; Zhong D
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):738-742. PubMed ID: 35922164
[No Abstract] [Full Text] [Related]
18. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
19. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience.
Cho J; Lee SE; Choi YL
Korean J Pathol; 2012 Apr; 46(2):115-22. PubMed ID: 23109990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]